Get the Stockscreener App
4.87
3.18%
0.15
After Hours:
4.75
-0.12
-2.46%
Champions Oncology Inc stock is traded at $4.87, with a volume of 19,879.
It is up +3.18% in the last 24 hours and up +15.40% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$4.72
Open:
$4.78
24h Volume:
19,879
Relative Volume:
0.41
Market Cap:
$66.20M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-8.6778
EPS:
-0.5612
Net Cash Flow:
$-4.86M
1W Performance:
+6.33%
1M Performance:
+15.40%
6M Performance:
-0.61%
1Y Performance:
-21.58%
1-Day Range:
$4.48
$4.91
1-Week Range:
$4.425
$5.0995
52-Week Range:
$3.6001
$7.1303
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
CN Energy Group (NASDAQ:CNEY) Stock Quotes, Forecast and News Summary - Benzinga
Patient Derived Xenograft or PDX Models Market Growth Factors & Key Statistics - Economica
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business - Yahoo Finance
Magnetar Financial LLC Buys Shares of 2,193,929 ChampionX Co. (NASDAQ:CHX) - Defense World
Its Stock Has Paid Off Big Time For Champion Homes Inc. - SETE News
P Schoenfeld Asset Management LP Makes New $5.45 Million Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Potential Price Increase for Champion Homes Inc. (SKY) After Recent Insider Activity - Knox Daily
Ameritas Investment Partners Inc. Has $1.97 Million Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
DekaBank Deutsche Girozentrale Makes New Investment in ChampionX Co. (NASDAQ:CHX) - Defense World
Renaissance Technologies LLC Takes Position in ChampionX Co. (NASDAQ:CHX) - MarketBeat
Benjamin Edwards Inc. Increases Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
622,616 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Renaissance Technologies LLC - Defense World
CHX Shares Experience Surge in Value - Knox Daily
6,878 Shares in ChampionX Co. (NASDAQ:CHX) Bought by Choreo LLC - Defense World
ChampionX Co. (NASDAQ:CHX) Shares Sold by Oppenheimer Asset Management Inc. - Defense World
Seven Eight Capital LP Acquires Shares of 56,674 ChampionX Co. (NASDAQ:CHX) - Defense World
Mutual of America Capital Management LLC Sells 237,847 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
Victory Capital Management Inc. Sells 56,930 Shares of ChampionX Co. (NASDAQ:CHX) - Defense World
State of New Jersey Common Pension Fund D Trims Stake in ChampionX Co. (NASDAQ:CHX) - Defense World
Meeder Advisory Services Inc. Has $217,000 Stock Holdings in ChampionX Co. (NASDAQ:CHX) - Defense World
Tumor Mice Model Market Detailed Summary, Industry Size and Future Growth Prospects To 2024-2032 - Cauverynews
Local official champions Blood Cancer Awareness Month to boost education - WTOV Steubenville
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - MSN
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - MSN
Champions Oncology upgraded to buy by Craig-Hallum - MSN
What is CSBR’s price-to-sales ratio telling us about the company’s value? - US Post News
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com Australia
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com India
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 - Investing.com
Earnings call: Champions Oncology reports positive momentum in Q1 FY2025 By Investing.com - Investing.com UK
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday - Benzinga
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2024 - Marketscreener.com
Stocks to Watch: Oxford Industries, Mobile Infrastructure, Champions Oncology - MarketWatch
Champions Oncology Shares Jump After Swinging to Profit, Posting Higher Revenue in 1Q - MarketWatch
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - wallstreet:online
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - StockTitan
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - Yahoo Finance
CSBR stock touches 52-week low at $3.94 amid market challenges - Investing.com
CSBR stock touches 52-week low at $3.94 amid market challenges - Investing.com UK
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - StockTitan
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - Yahoo Finance
Champions Oncology (NASDAQ:CSBR investor three-year losses grow to 58% as the stock sheds US$8.0m this past week - Simply Wall St
Patient Derived Xenograft (PDX) Models Market Projected Growth Outlined by Size, Share And Trends Report 20... - WhaTech
Champions of Health Care 2024: CHI Memorial Hospital - Chattanooga Times Free Press
CSBR stock touches 52-week low at $3.96 amid market challenges - Investing.com
Patient Derived Xenograft or PDX Models Market Business Insights, Key Trend Analysis - Economica
CSBR stock touches 52-week low at $4.42 amid market challenges - Investing.com Australia
CSBR stock touches 52-week low at $4.42 amid market challenges - Investing.com India
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):